Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Clinical Trial of the Efficacy of HAART Intensification With Maraviroc in HIV Virally Suppressed Patients With Cognitive Impairment

NCT01449006 is registered in ClinicalTrials.gov with Bruce Brew as lead sponsor.

NCT NCT01449006
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01449006 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Clinical Trial of the Efficacy of HAART Intensification With Maraviroc in HIV Virally Suppressed Patients With Cognitive Impairment
Lead sponsor
Bruce Brew
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2011
Completion date
September 30, 2014
Enrollment
19 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv associated neurocognitive disorders (hand), human immunodeficiency virus (hiv)